Provided by Tiger Trade Technology Pte. Ltd.

Novo-Nordisk A/S

42.53
-0.9200-2.12%
Post-market: 42.630.1000+0.24%19:59 EDT
Volume:8.86M
Turnover:377.57M
Market Cap:189.90B
PE:10.62
High:43.00
Open:42.73
Low:42.40
Close:43.45
52wk High:64.16
52wk Low:35.12
Shares:4.47B
Float Shares:3.19B
Volume Ratio:1.02
T/O Rate:0.28%
Dividend:1.72
Dividend Rate:4.05%
EPS(TTM):4.00
EPS(LYR):3.62
ROE:59.82%
ROA:18.73%
PB:5.83
PE(LYR):11.75

Loading ...

LIVE Markets-from Ozempic Face to K-Beauty Factories: the Next Beauty Bet

Reuters
·
Yesterday

Novo CEO Urges Staff to Embrace More Customer-Focused Culture

Reuters
·
Yesterday

Sector Update: Healthcare

MT Newswires Live
·
Yesterday

Novo Nordisk Stock (NVO) Is Falling Despite Rebrand to ‘Novo’ — Here’s Why

TIPRANKS
·
Yesterday

Lilly: Foundayo Has Captured Over 30% Of New Patient Share In The U.S. Oral Weight-Loss Drug Market

Bellwether Stocks Movement
·
Yesterday

Novo Nordisk rebranding as ‘Novo,’ announces cultural reset

TIPRANKS
·
Yesterday

GSK Doubles Down On Oncology: Buys Global Rights To Chimagen's Trispecific TCE For Up To $750 Million

Options & Short Sell
·
Yesterday

Lilly's Foundayo Grabs 30% Of New U.S. Orforglipron Patients, Chipping Away At Novo's Head Start

Options & Short Sell
·
Yesterday

Lilly Says Foundayo Has Captured over 30% of New US Patients on Oral Weight-Loss Drugs

Reuters
·
Yesterday

Novo Nordisk is Dropping Some Weight. it Still Faces a Bigger Challenge.

Dow Jones
·
Yesterday

Novo Nordisk A/S Series B Stock Rises Monday, Outperforms Market

Dow Jones
·
Yesterday

Dow Jones Top Company Headlines at 11 am ET: Microsoft Sets Limits for AI Models as Altman Details Control Risks | Dell's ...

Dow Jones
·
Sep 14

Novo Nordisk Kept at Hold as Analyst Maintains $47 Price Target Amid Strategic Uncertainty

TIPRANKS
·
Sep 14

Data Retention Terms Prompt Restraints on AI Model Use for Sensitive Operations

Deep News
·
Sep 14

Novo Signals New Direction of Travel with Rebrand

Dow Jones
·
Sep 14

AstraZeneca's Breast Cancer Drug Etcamah Hits A Phase 3 Setback, Clouding Billions In Potential Sales

Options & Short Sell
·
Sep 14

Novo Nordisk to Rebrand as Novo

Dow Jones
·
Sep 14

GE HealthCare Plans $1 Billion Sofie Deal To Tap Fast-Growing Radiopharmaceuticals Market

Options & Short Sell
·
Sep 14

Novo Nordisk Stock Slides as GLP-1 Fears Mount

TIPRANKS
·
Sep 12

Heart Disease, a Historic Strength for Big Pharma, Becomes a Weakness - Heard on the Street

Dow Jones
·
Sep 12